APO Research
Talk to an analyst

APO RESEARCH · REPORT

Teriparatide Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Teriparatide Injection Industry Growth and Trends Forecast to 2032

31 December 202592 pages

Choose your research edition.

Industry ResearchTeriparatide Injection Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Teriparatide Injection Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Teriparatide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Teriparatide Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Teriparatide Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Teriparatide Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Teriparatide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Teriparatide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Teriparatide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Teriparatide Injection include Shenzhen Salubris Pharmaceuticals Co., Ltd., Shanghai United Cell Biotechnology Co., Ltd., Pfenex Inc., Eli Lilly and Company and Alvogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Teriparatide Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Teriparatide Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Teriparatide Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Teriparatide Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Teriparatide Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Teriparatide Injection Market by Company

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Shanghai United Cell Biotechnology Co., Ltd.

Pfenex Inc.

Eli Lilly and Company

Alvogen

Teriparatide Injection Segment by Type

2.5ML

3.0ML

Teriparatide Injection Segment by Application

Hospital

Clinic

Others

Teriparatide Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Teriparatide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Teriparatide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Teriparatide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Teriparatide Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Teriparatide Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2.5ML Table 2. Major Company of 3.0ML Table 3. Global Teriparatide Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Teriparatide Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Teriparatide Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Teriparatide Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Teriparatide Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Teriparatide Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Teriparatide Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Teriparatide Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Teriparatide Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Teriparatide Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Teriparatide Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Teriparatide Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Teriparatide Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Teriparatide Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Teriparatide Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Teriparatide Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Teriparatide Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Teriparatide Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Teriparatide Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Teriparatide Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Teriparatide Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Teriparatide Injection Industry Trends Table 25. Teriparatide Injection Industry Drivers Table 26. Teriparatide Injection Industry Opportunities and Challenges Table 27. Teriparatide Injection Industry Restraints Table 28. Global Teriparatide Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Teriparatide Injection Revenue Market Share by Company (2021-2026) Table 30. Global Teriparatide Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Teriparatide Injection Sales Share by Company (2021-2026) Table 32. Global Teriparatide Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Teriparatide Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Teriparatide Injection Major Company Production Sites and Headquarters Table 35. Global Teriparatide Injection Company, Product Type & Application Table 36. Global Teriparatide Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Teriparatide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Teriparatide Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Teriparatide Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Teriparatide Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Teriparatide Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Teriparatide Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Teriparatide Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Teriparatide Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Teriparatide Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Teriparatide Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Teriparatide Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Teriparatide Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Teriparatide Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Teriparatide Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Teriparatide Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Teriparatide Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Teriparatide Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Teriparatide Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Teriparatide Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Teriparatide Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Teriparatide Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Teriparatide Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Teriparatide Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Teriparatide Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Teriparatide Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Teriparatide Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Teriparatide Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Teriparatide Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Teriparatide Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Teriparatide Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Teriparatide Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Teriparatide Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Teriparatide Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Shenzhen Salubris Pharmaceuticals Co., Ltd. Company Information Table 72. Shenzhen Salubris Pharmaceuticals Co., Ltd. Business Overview Table 73. Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Product Portfolio Table 75. Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Development Table 76. Shanghai United Cell Biotechnology Co., Ltd. Company Information Table 77. Shanghai United Cell Biotechnology Co., Ltd. Business Overview Table 78. Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Product Portfolio Table 80. Shanghai United Cell Biotechnology Co., Ltd. Recent Development Table 81. Pfenex Inc. Company Information Table 82. Pfenex Inc. Business Overview Table 83. Pfenex Inc. Teriparatide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfenex Inc. Teriparatide Injection Product Portfolio Table 85. Pfenex Inc. Recent Development Table 86. Eli Lilly and Company Company Information Table 87. Eli Lilly and Company Business Overview Table 88. Eli Lilly and Company Teriparatide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Eli Lilly and Company Teriparatide Injection Product Portfolio Table 90. Eli Lilly and Company Recent Development Table 91. Alvogen Company Information Table 92. Alvogen Business Overview Table 93. Alvogen Teriparatide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Alvogen Teriparatide Injection Product Portfolio Table 95. Alvogen Recent Development Table 96. North America Teriparatide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. North America Teriparatide Injection Sales by Country (2021-2026) & (K Units) Table 98. North America Teriparatide Injection Sales Market Share by Country (2021-2026) Table 99. North America Teriparatide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 100. North America Teriparatide Injection Sales Market Share Forecast by Country (2027-2032) Table 101. North America Teriparatide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Teriparatide Injection Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Teriparatide Injection Market Share by Country (2021-2026) Table 104. North America Teriparatide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Teriparatide Injection Market Share Forecast by Country (2027-2032) Table 106. Europe Teriparatide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Europe Teriparatide Injection Sales by Country (2021-2026) & (K Units) Table 108. Europe Teriparatide Injection Sales Market Share by Country (2021-2026) Table 109. Europe Teriparatide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 110. Europe Teriparatide Injection Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Teriparatide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Teriparatide Injection Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Teriparatide Injection Market Share by Country (2021-2026) Table 114. Europe Teriparatide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Teriparatide Injection Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Teriparatide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Teriparatide Injection Sales by Country (2021-2026) & (K Units) Table 118. Asia-Pacific Teriparatide Injection Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Teriparatide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 120. Asia-Pacific Teriparatide Injection Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Teriparatide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Teriparatide Injection Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Teriparatide Injection Market Share by Country (2021-2026) Table 124. Asia-Pacific Teriparatide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Teriparatide Injection Market Share Forecast by Country (2027-2032) Table 126. Latin America Teriparatide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Latin America Teriparatide Injection Sales by Country (2021-2026) & (K Units) Table 128. Latin America Teriparatide Injection Sales Market Share by Country (2021-2026) Table 129. Latin America Teriparatide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 130. Latin America Teriparatide Injection Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Teriparatide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Teriparatide Injection Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Teriparatide Injection Market Share by Country (2021-2026) Table 134. Latin America Teriparatide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Teriparatide Injection Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Teriparatide Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Teriparatide Injection Sales by Country (2021-2026) & (K Units) Table 138. Middle East and Africa Teriparatide Injection Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Teriparatide Injection Sales Forecast by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Teriparatide Injection Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Teriparatide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Teriparatide Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Teriparatide Injection Market Share by Country (2021-2026) Table 144. Middle East and Africa Teriparatide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Teriparatide Injection Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Teriparatide Injection Distributors List Table 149. Teriparatide Injection Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Teriparatide Injection Image Figure 2. Global Teriparatide Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Teriparatide Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Teriparatide Injection Sales (2021-2032) & (K Units) Figure 5. 2.5ML Image Figure 6. Global 2.5ML Sales YoY Growth (2021-2032) & (K Units) Figure 7. 3.0ML Image Figure 8. Global 3.0ML Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Teriparatide Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Teriparatide Injection Market Share by Type 2025 VS 2032 Figure 11. North America Teriparatide Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Teriparatide Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Teriparatide Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Teriparatide Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Teriparatide Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Teriparatide Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Teriparatide Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Teriparatide Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Teriparatide Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Teriparatide Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Teriparatide Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Teriparatide Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Teriparatide Injection Market Share by Application 2025 VS 2032 Figure 31. North America Teriparatide Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Teriparatide Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Teriparatide Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Teriparatide Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Teriparatide Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Teriparatide Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Teriparatide Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Teriparatide Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Teriparatide Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Teriparatide Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Teriparatide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Teriparatide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Teriparatide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Teriparatide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Teriparatide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Teriparatide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Teriparatide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Teriparatide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Teriparatide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Teriparatide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Teriparatide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Teriparatide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Teriparatide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Teriparatide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Teriparatide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Teriparatide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Teriparatide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Teriparatide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Teriparatide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Teriparatide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Teriparatide Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Teriparatide Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5ML
  • 3.0ML
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Shenzhen Salubris Pharmaceuticals Co., Ltd.
  • Shanghai United Cell Biotechnology Co., Ltd.
  • Pfenex Inc.
  • Eli Lilly and Company
  • Alvogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Teriparatide Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Teriparatide Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Teriparatide Injection Market by Type
  6. 1.3.1 2.5ML
  7. 1.3.2 3.0ML
  8. 1.4 Global Teriparatide Injection Market Size by Type
  9. 1.4.1 Global Teriparatide Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Teriparatide Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Teriparatide Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Teriparatide Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Teriparatide Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Teriparatide Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Teriparatide Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Teriparatide Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Teriparatide Injection Industry Trends
  2. 2.2 Teriparatide Injection Industry Drivers
  3. 2.3 Teriparatide Injection Industry Opportunities and Challenges
  4. 2.4 Teriparatide Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Teriparatide Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Teriparatide Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Teriparatide Injection Price (2021-2026)
  4. 3.4 Global Teriparatide Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Teriparatide Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Teriparatide Injection Company, Product Type & Application
  7. 3.7 Global Teriparatide Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Teriparatide Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Teriparatide Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Teriparatide Injection Tier 1, Tier 2, and Tier 3
4 Teriparatide Injection Regional Status and Outlook
  1. 4.1 Global Teriparatide Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Teriparatide Injection Historic Market Size by Region
  3. 4.2.1 Global Teriparatide Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Teriparatide Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Teriparatide Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Teriparatide Injection Forecasted Market Size by Region
  7. 4.3.1 Global Teriparatide Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Teriparatide Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Teriparatide Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Teriparatide Injection by Application
  1. 5.1 Teriparatide Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Teriparatide Injection Market Size by Application
  6. 5.2.1 Global Teriparatide Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Teriparatide Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Teriparatide Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Teriparatide Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Teriparatide Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Teriparatide Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Teriparatide Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Teriparatide Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shenzhen Salubris Pharmaceuticals Co., Ltd.
  2. 6.1.1 Shenzhen Salubris Pharmaceuticals Co., Ltd. Company Information
  3. 6.1.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. Business Overview
  4. 6.1.3 Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Product Portfolio
  6. 6.1.5 Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments
  7. 6.2 Shanghai United Cell Biotechnology Co., Ltd.
  8. 6.2.1 Shanghai United Cell Biotechnology Co., Ltd. Company Information
  9. 6.2.2 Shanghai United Cell Biotechnology Co., Ltd. Business Overview
  10. 6.2.3 Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Product Portfolio
  12. 6.2.5 Shanghai United Cell Biotechnology Co., Ltd. Recent Developments
  13. 6.3 Pfenex Inc.
  14. 6.3.1 Pfenex Inc. Company Information
  15. 6.3.2 Pfenex Inc. Business Overview
  16. 6.3.3 Pfenex Inc. Teriparatide Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfenex Inc. Teriparatide Injection Product Portfolio
  18. 6.3.5 Pfenex Inc. Recent Developments
  19. 6.4 Eli Lilly and Company
  20. 6.4.1 Eli Lilly and Company Company Information
  21. 6.4.2 Eli Lilly and Company Business Overview
  22. 6.4.3 Eli Lilly and Company Teriparatide Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly and Company Teriparatide Injection Product Portfolio
  24. 6.4.5 Eli Lilly and Company Recent Developments
  25. 6.5 Alvogen
  26. 6.5.1 Alvogen Company Information
  27. 6.5.2 Alvogen Business Overview
  28. 6.5.3 Alvogen Teriparatide Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Alvogen Teriparatide Injection Product Portfolio
  30. 6.5.5 Alvogen Recent Developments
7 North America by Country
  1. 7.1 North America Teriparatide Injection Sales by Country
  2. 7.1.1 North America Teriparatide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Teriparatide Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Teriparatide Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Teriparatide Injection Market Size by Country
  6. 7.2.1 North America Teriparatide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Teriparatide Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Teriparatide Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Teriparatide Injection Sales by Country
  2. 8.1.1 Europe Teriparatide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Teriparatide Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Teriparatide Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Teriparatide Injection Market Size by Country
  6. 8.2.1 Europe Teriparatide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Teriparatide Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Teriparatide Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Teriparatide Injection Sales by Country
  2. 9.1.1 Asia-Pacific Teriparatide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Teriparatide Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Teriparatide Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Teriparatide Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Teriparatide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Teriparatide Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Teriparatide Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Teriparatide Injection Sales by Country
  2. 10.1.1 South America Teriparatide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Teriparatide Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Teriparatide Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Teriparatide Injection Market Size by Country
  6. 10.2.1 South America Teriparatide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Teriparatide Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Teriparatide Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Teriparatide Injection Sales by Country
  2. 11.1.1 Middle East and Africa Teriparatide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Teriparatide Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Teriparatide Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Teriparatide Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Teriparatide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Teriparatide Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Teriparatide Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Teriparatide Injection Value Chain Analysis
  2. 12.1.1 Teriparatide Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Teriparatide Injection Production Mode & Process
  7. 12.2 Teriparatide Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Teriparatide Injection Distributors
  10. 12.2.3 Teriparatide Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst